TNL Mediagene Pursues Cost-Efficient Expansion with New C-Level Hires and Strategic M&A Focus
- Revenue grew 35.3% to $48.5M in FY2024
- Gross margin improved to 36.6% in FY2024
- Adjusted EBITDA margin improved to -1.8% from -2.8% year-over-year
- Successful track record of acquiring and integrating 10 companies since 2018
- Strategic appointments of experienced C-level executives strengthen governance and HR functions
- Company remains unprofitable with negative Adjusted EBITDA of -$854,174
- Gross margin of 36.6% in 2024 still below 2022 levels of 38.7%
As part of its Global Talent Management pillar, the company announced the appointment of Aya Miyake as Chief Governance Officer and Carly Ma as Chief Human Resources Officer.
Aya Miyake brings over two decades of capital markets and business experience including executive roles at Tokyo Stock Exchange, Osaka Securities Exchange and Automotive Fund. Aya's extensive experience includes corporate governance, public listings, capital raising, investor relations and compliance. Aya's role as Chief Governance Officer at TNL Mediagene will strengthen the company's expertise in public company matters and bolster its C-level oversight and control functions.
Carly Ma brings over a decade of HR experience at multinational corporations with roles at Porsche Taiwan Motors, a subsidiary of Porsche A.G.
"Aya's wealth of experience in the capital markets and adjacent areas will bolster our institutional knowledge in all areas of public company matters as well as enhance our C-level oversight and control functions. Carly's experience in multinational corporate HR will bring HR best practices to our company, help us acquire and retain talent as well as optimize our talent pool going forward. We are thrilled to welcome them to the TNL Mediagene family" Co-Founder & CEO Joey Chung said.
As part of the Global Strategic M&A pillar, the company gave an update on its M&A strategy including its focus on enhancing revenue growth and revenue diversification via M&A. The company's geographic focus areas for strategic expansion include the
"M&A has been a part of our DNA for some time now. We have acquired and integrated 10 companies since 2018 and maintain an active pipeline of M&A opportunities. We have close relationships with our bankers and continue to actively screen targets with them. In the near-term we see opportunities in
TNL Mediagene believes M&A is a key component of its financial performance and intends to be acquisitive going forward.
"In FY2024 we achieved
Summary Financials:
For the year ended December 31, | |||
($ in dollars, unless otherwise stated) | 2022 | 2023 | 2024 |
Revenue | 20,009,994 | 35,838,780 | 48,493,897 |
Growth % | 79.1 % | 35.3 % | |
Gross Profit | 7,741,196 | 12,651,384 | 17,738,557 |
Margin % | 38.7 % | 35.3 % | 36.6 % |
Adjusted EBITDA | -1,687,729 | -998,162 | -854,174 |
Margin % | -8.4 % | -2.8 % | -1.8 % |
The condensed financial information presented in this press release should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2024 included in TNL Mediagene's annual report on Form 20-F filed with the SEC on April 30, 2025, which provides a more complete discussion of its accounting policies and certain other information.
About TNL Mediagene
Headquartered in
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene's future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing," "target," "seek" or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements in this communication include, but are not limited to, statements in the section entitled "2025 Initiatives and Outlook" and "Management Commentary" such as statements about TNL Mediagene's future business plan and growth strategies and statements by TNL Mediagene's CEO and president. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene's filings with the Securities and Exchange Commission. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.
Use of Non-IFRS Financial Measures
In this press release we have included adjusted EBITDA, a non-IFRS financial measure, which is a key measure used by our management and board of directors in evaluating our operating performance.
Adjusted EBITDA is our preferred metric for profitability because we believe it facilitates operating performance comparisons on a period-to-period basis and excludes items that we do not consider to be indicative of our core operating performance.
Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under IFRS. Some of these limitations are:
- although amortization and depreciation are non-cash charges, the assets being amortized and depreciated may have to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
- adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA does not reflect the potentially dilutive impact of equity-based compensation; and
- other companies, including our competitors in various industries, may calculate adjusted EBITDA or similarly titled measures differently, which reduces its usefulness as a comparative measure.
We define adjusted EBITDA as profit (loss) for the period excluding (i) non-cash items such as depreciation expenses, amortization expenses, stock-based compensation expenses and impairment loss on intangible assets and (ii) extraordinary items associated with one-time events and transactions, such as one-time transaction-related expenses not eligible for capitalization.
Reconciliation of Non-IFRS Financial Measures:
For the year ended December 31, | ||||||||||
($ in dollars, unless otherwise stated) | 2022 | 2023 | 2024 | |||||||
Loss for the year | $ | (11,394,768) | $ | (1,215,789) | ||||||
Add (less): | ||||||||||
Income tax (benefit) expense | (247,177) | (591,082) | (307,246) | |||||||
Finance costs | 137,029 | 298,958 | 8,167,872 | |||||||
Other gains and losses(1) | 8,174,802 | (5,458,803) | 851,689 | |||||||
Other income | (75,576) | (409,555) | (58,024) | |||||||
Interest Income | (10,994) | (19,340) | (21,773) | |||||||
Operating loss | $ | (3,416,684) | $ | (7,395,611) | ||||||
Add: | ||||||||||
Depreciation expenses | 433,262 | 1,025,783 | 1,139,488 | |||||||
Amortization expenses | 1,058,392 | 1,809,774 | 2,101,080 | |||||||
Stock-based compensation expense | 237,301 | 118,800 | 250,952 | |||||||
Impairment loss on intangible assets(2) | — | 298,424 | 29,026,050 | |||||||
One-time transaction-related expenses(3) | — | 3,144,668 | 42,972,458 | |||||||
Adjusted EBITDA | (1,687,729) | (998,162) | (854,174) | |||||||
Adjusted EBITDA Margin (%) | -8.4 | % | -2.8 | % | -1.8 | % |
(1) | Other gains and losses for the year ended December 31, 2022 comprise an | |||||||||||
(2) | For the year ended December 31, 2023, we incurred approximately | |||||||||||
(3) | For the year ended December 31, 2023, one-time transaction-related expenses comprise the professional service fees related to (i) the merger with Mediagene; and (ii) preparation for our merger (the "Merger") with Blue Ocean Acquisition Corporation ("Blue Ocean") and the listing on the Nasdaq, which were not eligible for capitalization. For the year ended December 31, 2024, one-time transaction-related expenses comprise (i) the professional service fees related to the closing of the Merger and listing on the Nasdaq of |
View original content to download multimedia:https://www.prnewswire.com/news-releases/tnl-mediagene-pursues-cost-efficient-expansion-with-new-c-level-hires-and-strategic-ma-focus-302448766.html
SOURCE TNL Mediagene